Download Files:
GSK097
SKU
HY-132232-Get quote
Category Reference compound
Tags Cancer, Epigenetic Reader Domain, Epigenetics
Products Details
Product Description
– GSK097 is a potent and selective Inhibitor of the second bromodomain (BD2) of the bromodomain and extra-terminal domain (BET) proteins. GSK097 displays 2000-fold selective for BD2 over BD1 (BRD4 data) with >1 mg/mL solubility in FaSSIF media[1].
Web ID
– HY-132232
Shipping
– Room temperature
Applications
– Cancer-programmed cell death
Molecular Formula
– C19H21N3O3
References
– [1]Harrison LA, et al. Identification of a Series of N-Methylpyridine-2-carboxamides as Potent and Selective Inhibitors of the Second Bromodomain (BD2) of the Bromo and Extra Terminal Domain (BET) Proteins [published online ahead of print, 2021 Jul 7]. J Med Chem. 2021;10.1021/acs.jmedchem.0c02155.
CAS Number
– 2159137-02-5
Molecular Weight
– 339.39
SMILES
– O=C(C1=NC([C@@H](O)C2=CC=CC=C2)=CC(C(N[C@@H]3[C@@H](C)C3)=O)=C1)NC
Clinical Information
– No Development Reported
Research Area
– Cancer
Solubility
– 10 mM in DMSO
Target
– Epigenetic Reader Domain
Pathway
– Epigenetics
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.